Literature DB >> 12049250

Intestinal capillariass in Egypt epideiologigal background.

Nadia A el-Dib1, Wahid H Doss.   

Abstract

Intestinal capillariasis has been reported in Egypt in 1989. Since that time, 44 cases have been diagnosed. Most of the detected cases were females (37), while males were only 7. Their ages ranged from 10 to 65 years, however most of them were between 20 to 40 years. Twenty-six cases were from the northern part of Upper Egypt, particularly Bani-Suif and El-Menia Governorates. Patients presented with borborygmi, chronic diarrhea, vomiting, loss of weight, lower limb edema and electrolyte imbalance for durations ranging from one month to two years. Morbidity and mortality of the disease in Egyptian cases are described. Some patients gave history of eating raw whole fish, while others gave history of eating raw parts of fish or half-cooked fish. Diagnosis was based on the clinical picture, and confirmed stool analysis. Differential diagnosis was discussed and the cost paid by patients to reach the correct diagnosis was estimated. Suggestions about the way with which the parasite was introduced and maintained in Egypt were mentioned.

Entities:  

Mesh:

Year:  2002        PMID: 12049250

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  3 in total

1.  Capillaria philippinensis in Upper Egypt: has it become endemic?

Authors:  Rasha A H Attia; Mohammed E M Tolba; Doaa A Yones; Hanaa Y Bakir; Hanan E M Eldeek; Shereef Kamel
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

Review 2.  Human intestinal capillariasis in Thailand.

Authors:  Prasert Saichua; Choosak Nithikathkul; Natthawut Kaewpitoon
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

3.  Comparison of the diagnostic performance of microscopic examination, Copro-ELISA, and Copro-PCR in the diagnosis of Capillaria philippinensis infections.

Authors:  Mervat M Khalifa; Salma M Abdel-Rahman; Hanaa Y Bakir; Ragaa A Othman; Mohamed A El-Mokhtar
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.